IRIS
Ceribelli, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.848
AS - Asia 3.246
EU - Europa 1.343
AF - Africa 703
SA - Sud America 610
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 7
Totale 11.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.671
SG - Singapore 1.903
CN - Cina 634
SC - Seychelles 610
BR - Brasile 503
IT - Italia 400
VN - Vietnam 293
FI - Finlandia 203
IE - Irlanda 145
DE - Germania 125
GB - Regno Unito 94
HK - Hong Kong 93
IN - India 93
CA - Canada 88
FR - Francia 88
NL - Olanda 66
AR - Argentina 41
MX - Messico 33
BD - Bangladesh 30
SE - Svezia 30
NG - Nigeria 29
RU - Federazione Russa 28
ZA - Sudafrica 24
IQ - Iraq 23
PL - Polonia 23
EC - Ecuador 20
JP - Giappone 20
MK - Macedonia 20
TR - Turchia 20
ES - Italia 19
PK - Pakistan 19
CZ - Repubblica Ceca 15
ID - Indonesia 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 11
CL - Cile 11
CO - Colombia 11
MA - Marocco 11
BE - Belgio 10
CR - Costa Rica 10
SA - Arabia Saudita 10
UA - Ucraina 10
IL - Israele 9
GR - Grecia 8
JM - Giamaica 8
PE - Perù 8
TN - Tunisia 8
UZ - Uzbekistan 8
VE - Venezuela 8
AT - Austria 7
JO - Giordania 7
KR - Corea 7
MY - Malesia 7
TT - Trinidad e Tobago 7
AU - Australia 6
EG - Egitto 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
NP - Nepal 5
BG - Bulgaria 4
DK - Danimarca 4
DZ - Algeria 4
KZ - Kazakistan 4
NO - Norvegia 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
EE - Estonia 3
GP - Guadalupe 3
KE - Kenya 3
LT - Lituania 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
AO - Angola 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
ML - Mali 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 11.744
Salva come PNG Salva come JPEG
Città #
Singapore 803
Chandler 606
Ashburn 588
San Jose 535
Dallas 404
The Dalles 297
Shanghai 232
Helsinki 203
New York 196
Council Bluffs 187
Boardman 169
Beijing 168
Dublin 142
Los Angeles 141
Wilmington 138
Ho Chi Minh City 116
Milan 113
Hong Kong 83
Santa Clara 78
Hanoi 67
Paris 59
San Mateo 54
Phoenix 48
Amsterdam 45
Princeton 39
São Paulo 39
Rome 37
London 36
Buffalo 35
Ann Arbor 34
Chicago 32
Falkenstein 31
Benin City 27
Lawrence 27
Pune 27
Brooklyn 26
Naples 26
Columbus 23
Leawood 23
Belo Horizonte 20
Montreal 20
North Bergen 20
Boston 19
Toronto 19
Seattle 18
Warsaw 18
Chennai 17
Woodbridge 17
Frankfurt am Main 16
San Francisco 16
Stockholm 16
Atlanta 15
Rio de Janeiro 15
San Diego 15
Fairfield 14
Mexico City 14
Orem 14
Da Nang 13
Tokyo 13
Assago 12
Philadelphia 12
Brasília 11
Brno 11
Dhaka 11
Haiphong 11
Houston 11
Johannesburg 11
Miami 11
Brussels 10
Charlotte 10
San José 10
Baghdad 9
Munich 9
Skopje 9
Aurora 8
Curitiba 8
Denver 8
Hangzhou 8
Hyderabad 8
Pasadena 8
Quito 8
Sassari 8
Dubai 7
Figino 7
Hillsboro 7
Jacksonville 7
Kingston 7
Queens 7
Santiago 7
Tashkent 7
Trieste 7
Turin 7
Amman 6
Detroit 6
Fortaleza 6
Hải Dương 6
Istanbul 6
Jakarta 6
Lima 6
Osasco 6
Totale 6.603
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 707
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 232
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 166
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 164
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 151
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 143
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 140
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 136
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 135
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 131
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 130
Lessons learned from twins in autoimmune and chronic inflammatory diseases 127
Safety issues and concerns of new immunomodulators in rheumatology 121
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 121
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 121
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 118
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 118
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 113
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 110
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 110
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 110
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 109
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 109
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 106
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies 105
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 101
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 100
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 99
Epigenetic Methods and Twin Studies 98
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 98
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 98
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 96
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 95
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 92
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 91
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 90
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 90
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 89
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 89
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 88
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 86
Cancer in connective tissue disease 86
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 85
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 85
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 85
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 83
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 83
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 81
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 81
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 81
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 80
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 80
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 79
MicroRNAs in rheumatoid arthritis 79
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 79
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 78
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 78
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 78
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 78
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits 77
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 77
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 76
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 75
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 74
MicroRNAs and autoimmunity 74
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 74
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 73
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 73
Seronegative reactive spondyloarthritis and the skin 73
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 72
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 71
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 71
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 70
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 69
Medical cannabis and cannabinoids in rheumatology: where are we now? 68
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 67
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 67
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 66
Cardiological features in idiopathic inflammatory myopathies 65
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 64
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 64
MicroRNA-146a in autoimmunity and innate immune responses 63
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 63
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 62
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 62
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 62
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 62
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 62
PREVALENZA DI AUTOANTICORPI ANTI-KU NELLE MALATTIE AUTOIMMUNI SISTEMICHE E CARATTERISTICHE CLINICO-SIEROLOGICHE ASSOCIATE 62
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 61
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset 60
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 59
Systemic rheumatic diseases: From biological agents to small molecules 59
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 59
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 59
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients 59
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 58
The geoepidemiology of autoimmune liver disease 58
Neuropsychiatric aid in children born to patients with rheumatic diseases 58
ANTICORPI ANTI-CCP: LIMITI E SVANTAGGI 58
Totale 9.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022135 0 0 0 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20252.428 38 37 636 57 83 227 144 131 293 400 207 175
2025/20264.814 792 265 412 341 191 247 1.230 227 204 264 320 321
2026/20271.530 241 272 696 321 0 0 0 0 0 0 0 0
Totale 11.841